Clinical Trial
doi: 10.1007/BF01655192.
Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status
- PMID: 4060747
- DOI: 10.1007/BF01655192
Item in Clipboard
Clinical Trial
Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status
World J Surg.
1985 Oct.
No abstract available
Similar articles
-
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.Lancet. 1988 Nov 12;2(8620):1095-9. Lancet. 1988. PMID: 2903322 Clinical Trial.
-
Antiestrogen treatment of postmenopausal women with primary high risk breast cancer.Breast Cancer Res Treat. 1983;3(1):77-84. doi: 10.1007/BF01806237. Breast Cancer Res Treat. 1983. PMID: 6347277 Clinical Trial.
-
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.Cancer. 1989 Nov 1;64(9):1819-23. doi: 10.1002/1097-0142(19891101)64:9<1819::aid-cncr2820640910>3.0.co;2-n. Cancer. 1989. PMID: 2790695 Clinical Trial.
-
Adjuvant systemic therapy in primary breast cancer.Acta Chir Scand Suppl. 1984;519:43-53. Acta Chir Scand Suppl. 1984. PMID: 6393664 Review. No abstract available.
-
Who needs steroid receptor assays?Lancet. 1989 May 20;1(8647):1126-7. doi: 10.1016/s0140-6736(89)92395-7. Lancet. 1989. PMID: 2566061 Review. No abstract available.
Cited by
-
The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. doi: 10.1007/BF02934996. Med Oncol Tumor Pharmacother. 1986. PMID: 3543533 Review.
-
A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC).Transl Gastroenterol Hepatol. 2021 Jan 5;6:9. doi: 10.21037/tgh.2020.02.16. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 33409403 Free PMC article.
-
Adjuvant systemic therapy: state of the art, 1989.Breast Cancer Res Treat. 1989 Oct;14(1):3-22. doi: 10.1007/BF01805971. Breast Cancer Res Treat. 1989. PMID: 2690970 Review.
-
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.Breast Cancer Res Treat. 1995;36(1):11-21. doi: 10.1007/BF00690180. Breast Cancer Res Treat. 1995. PMID: 7579502
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical